Podiatrists in Shepherdsville, KY Accepting Medicare

6 Podiatrists found. Showing 1 - 6

Dr. Vipul Ramanbhai Patel, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 421 Adam Shepherd Pkwy, Suite 100, Shepherdsville, KY 40165 Phone: 502-543-1553    Fax: 502-543-1558

Comprehensive Foot & Ankle Centers Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 1905 W Hebron Ln, Suite 204, Shepherdsville, KY 40165 Phone: 502-797-3338    Fax: 502-957-1731

Dr. Samual Paul Gracey, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 1905 W Hebron Ln Ste 204, Shepherdsville, KY 40165 Phone: 502-797-3338

Bullitt County Foot And Ankle Center Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 421 Adam Shepherd Pkwy, Suite 100, Shepherdsville, KY 40165 Phone: 502-543-1553    Fax: 502-543-1558

Christopher W Hubbard, DPM Podiatrist - Primary Podiatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1905 W Hebron Ln, Shepherdsville, KY 40165 Phone: 502-797-3338    Fax: 502-957-1731

Kathleen M Pyatak-hugar, DPM Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 1905 W Hebron Ln Ste 204, Shepherdsville, KY 40165 Phone: 502-797-3338    Fax: 502-957-1731

News Archive

Investigational drug tolvaptan treats hyponatremia

Results of the two largest studies on hyponatremia, SALT-1 and SALT-2, presented Nov. 14 at the American Heart Association's Scientific Sessions in Chicago, found that the investigational drug tolvaptan treated hyponatremia - water intoxication - faster and more effectively than available treatments.

Celgene to discontinue treatment with REVLIMID in phase III ORIGIN trial

Celgene Corporation today announced that after consultation with the U.S. Food and Drug Administration Celgene will discontinue treatment with REVLIMID (lenalidomide) in the open-label, phase III ORIGIN trial, which enrolled 450 patients in over 100 sites in 26 countries.

TxCell to deliver two presentations on Col-Treg and Ovasave at ISCT Annual Meeting

TxCell SA, a biotechnology company developing innovative, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Dr. Arnaud Foussat, VP Research and New Products, TxCell, will deliver two presentations at the 21st Annual Meeting of the International Society of Cellular Therapy, May 27-30, 2015, in Las Vegas, Nevada, US.

Medical Acoustics receives UB CAT/NYSTAR grant

Medical Acoustics LLC, a commercial-stage medical device company which employs acoustic technologies for diagnostic and therapeutic medical applications, today announced that it has been awarded a UB CAT/NYSTAR grant.

NCKU student receives Graduate/Postdoctoral Travel Award from ASBMB

Wan-Pei Su, a graduate student of Molecular Medicine at National Cheng Kung University (NCKU), southern Taiwan, has received a Graduate/Postdoctoral Travel Award from the American Society for Biochemistry and Molecular Biology (ASBMB) to attend the annual conference on Experimental Biology (EB) in San Diego in April 2012.

Read more Medical News

› Verified 2 days ago